Table 2.
ERPs amplitude in study phase (M ± SD).
Type | P1(uV) | N170(uV) | P2(uV) | N300(uV) | ||||
---|---|---|---|---|---|---|---|---|
FN group | Control group | FN group | Control group | FN group | Control group | FN group | Control group | |
High | 6.64 ± 0.75 | 8.16 ± 1.16 | −10.40 ± 1.11 | −12.604 ± 1.03 | 4.50 ± 0.99 | 1.13 ± 1.02 | −8.83 ± 0.63 | −5.90 ± 0.75 |
Middle | 6.31 ± 0.80 | 6.66 ± 1.19 | −10.20 ± 1.01 | −12.511 ± 0.97 | 3.82 ± 0.72 | 0.64 ± 0.87 | −7.52 ± 0.62 | −4.37 ± 1.00 |
Low | 7.83 ± 0.80 | 6.64 ± 1.19 | −12.08 ± 1.00 | −10.571 ± 1.04 | 3.53 ± 0.95 | 0.03 ± 0.96 | −6.91 ± 0.79 | −4.14 ± 0.95 |
Total | 3.98 ± 0.87 | 0.56 ± 0.94 | −7.75 ± 0.66 | −4.81 ± 0.87 |